Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 4:00 PM
Ignite Modification Date:
2025-12-26 @ 4:00 PM
NCT ID:
NCT03861806
Eligibility Criteria:
Inclusion Criteria:
* Unilateral ischemic stroke with residual arm weakness (Fugl-Meyer Upper Limb \< 60) more than 6 months prior to enrollment.
* Ability to give informed consent and understand the tasks involved.
* Age over 18 years.
Exclusion Criteria:
* Hemorrhagic Stroke
* Contraindications to TMS: history of seizure/epilepsy, pacemaker, other neurological disorders, brain surgery, metal implant/fragment in the head, pregnancy
* Taking medications or substances that are known to affect PAS-induced plasticity within the past 2 months: selective serotonin reuptake inhibitors, dopamine, dopamine agonists, haloperidol, lithium, acetylcholinesterase inhibitors, beta-blockers, nimodipine, levetiracetam, ethosuximide, benzodiazepines, baclofen, nicotine
* Peripheral neuropathy or history of nerve injury in the paretic upper limb.
* Social and/or personal circumstances that interfere with ability to return for all study visits.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT03861806
Study Brief:
Protocol Section:
NCT03861806